Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone for Hypercalciuria in Type 1 Diabetes
NCT03325114Phase 2Terminated
- Sponsor
- University of Rochester
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorthalidone in hypercalciuria, sponsored by University of Rochester. Started Jun 2019; status: terminated.
02
Drugs
chlorthalidone
03
Conditions
hypercalciuria
Beyond the preview
Go deeper on NCT03325114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325114.